Abstract:Importance: Prior studies have demonstrated lower all-cause mortality in individuals who are overweight compared with those with normal body mass index (BMI), but whether this may come at the cost of greater burden of cardiovascular disease (CVD) is unknown.Objective: To calculate lifetime risk estimates of incident CVD and subtypes of CVD and to estimate years lived with and without CVD by weight status.Design, Setting, and Participants: In this population-based study, we used pooled individual-level data from adults (baseline age, 20-39, 40-59, and 60-79 years) across 10 large US prospective cohorts, with 3.2 million person-years of follow-up from 1964 to 2015. All participants were free of clinical CVD at baseline with available BMI index and CVD outcomes data. Data were analyzed from October 2016 to July 2017.Exposures: World Health Organization-standardized BMI categories.Main Outcomes and Measures: Total CVD and CVD subtype, including fatal and nonfatal coronary heart disease, stroke, congestive heart failure, and other CVD deaths. Heights and weights were measured directly by investigators in each study, and BMI was calculated as weight in kilograms divided by height in meters squared. We performed (1) modified Kaplan-Meier analysis to estimate lifetime risks, (2) adjusted competing Cox models to estimate joint cumulative risks for CVD or noncardiovascular death, and (3) the Irwin restricted mean to estimate years lived free of and with CVD.Results: Of the 190 672 in-person examinations included in this study, the mean (SD) age was 46.0 (15.0) years for men and 58.7 (12.9) years for women, and 140 835 patients (73.9%) were female. Compared with individuals with a normal BMI (defined as a BMI of 18.5 to 24.9), lifetime risks for incident CVD were higher in middle-aged adults in the overweight and obese groups. Compared with normal weight, among middle-aged men and women, competing hazard ratios for incident CVD were 1.21 (95% CI, 1.14-1.28) and 1.32 (95% CI, 1.24-1.40), respectively, for overweight (BMI, 25.0-29.9), 1.67 (95% CI, 1.55-1.79) and 1.85 (95% CI, 1.72-1.99) for obesity (BMI, 30.0-39.9), and 3.14 (95% CI, 2.48-3.97) and 2.53 (95% CI, 2.20-2.91) for morbid obesity (BMI, ≥40.0). Higher BMI had the strongest association with incident heart failure among CVD subtypes. Average years lived with CVD were longer for middle-aged adults in the overweight and obese groups compared with adults in the normal BMI group. Similar patterns were observed in younger and older adults.Conclusions and Relevance: In this study, obesity was associated with shorter longevity and significantly increased risk of cardiovascular morbidity and mortality compared with normal BMI. Despite similar longevity compared with normal BMI, overweight was associated with significantly increased risk of developing CVD at an earlier age, resulting in a greater proportion of life lived with CVD morbidity.

Adiposity, Adulthood Weight Change, and Risk of Incident Hepatocellular Carcinoma

Supplementary Data from Adiposity, Adulthood Weight Change, and Risk of Incident Hepatocellular Carcinoma

Associations of Weight Gain from Early to Middle Adulthood with Major Health Outcomes Later in Life.

Longitudinal trajectories of BMI and cardiovascular disease risk: The national longitudinal study of adolescent health

Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity

Weight Gain During Early Adulthood, Trajectory of Body Shape and the Risk of Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study among Women.

Association of Adult Weight Gain with Major Health Outcomes among Middle-aged Chinese Persons with Low Body Weight in Early Adulthood

Relationship of Weight Change Patterns from Young to Middle Adulthood with Incident Cardiovascular Diseases.

Young Adulthood and Adulthood Adiposity in Relation to Incidence of Pancreatic Cancer: a Prospective Study of 0.5 Million Chinese Adults and a Meta-Analysis

Body mass index trajectories, weight gain and risks of liver and biliary tract cancers.

Weight changes from early to middle adulthood and cardiometabolic multimorbidity later in life among middle-aged and older adults: a retrospective cohort study from the NHANES 1999-2018

Weight Change across Adulthood in Relation to Non-Alcoholic Fatty Liver Disease among Non-Obese Individuals

Adiposity in relation to risks of fatty liver, cirrhosis and liver cancer: a prospective study of 0.5 million Chinese adults

Weight History and Risk of Endometrial Cancer among Chinese Women

Adiposity change and mortality in middle-aged to older Chinese: an 8-year follow-up of the Guangzhou Biobank Cohort Study

Early Adulthood Weight Change, Midlife “life’s Essential 8” Health Status and Risk of Cardiometabolic Diseases: a Chinese Nationwide Cohort Study

Childhood Adiposity and Nonalcoholic Fatty Liver Disease in Adulthood.

Association of early adulthood weight and subsequent weight change with cardiovascular diseases: Findings from REACTION study

Lifetime Body Weight Trajectories and Risk of Kidney Cancer: A Large US Prospective Cohort Study

Association of Weight Loss from Early to Middle Adulthood and Incident Hypertension Risk Later in Life

Association of weight change with all-cause and cause-specific mortality: an age-stratified analysis